The role of minimally invasive gynecologic surgeons in the era of subspecialties: when to refer and consult : Current Opinion in Obstetrics and Gynecology

Secondary Logo

Journal Logo

MINIMALLY INVASIVE GYNECOLOGIC PROCEDURES: Edited by Matthew T. Siedhoff and Nisse V. Clark

The role of minimally invasive gynecologic surgeons in the era of subspecialties: when to refer and consult

Shu, Michaela,b; Sosa, J’Leisea,b,c; Reyes, Henry D.a,b,d; Eddib, Abeera,b,e; Eswar, Alexandera,b,f

Author Information
Current Opinion in Obstetrics and Gynecology 34(4):p 190-195, August 2022. | DOI: 10.1097/GCO.0000000000000795

Abstract

Purpose of review 

Minimally invasive gynecologic surgery (MIGS) is a subspecialty focus of obstetrics and gynecology with focused expertise on complex benign gynecologic disorders. To date, no formal recommendations have been made in defining a referral system for MIGS. This article reviews the evidence regarding common disorders and procedures and their outcomes, and posits a basis for MIGS referral.

Recent findings 

In instances where intraoperative and perioperative features may pose clinical challenges to the surgeon and ultimately the patient, the literature suggests the following scenarios may have adverse outcomes, and therefore, benefit from the skills of MIGS subspecialists: fibroids – at least five myomas, myoma size at least 9 cm, and suspected myoma weight at least 500 g; endometriosis – presence of endometrioma(s), suspected stage III/IV endometriosis, and requirement for advanced adjunct procedures; hysterectomy – uteri at least 250 g or 12 weeks estimated size, at least three prior laparotomies, obesity, and complex surgical history with suspected adhesive disease.

Summary 

A referral system for MIGS subspecialists has proven benefits for both the gynecologic surgical community as well as the patients and their outcomes. This article provides evidence for collaboration with MIGS especially as it relates to leiomyomatous uteri, endometriosis, and complex hysterectomies.

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid